On November 10, a Vietnamese medical delegation made a special visit to Guangzhou RoyalLee Cancer Hospital, conducting in-depth inspection and research on internationalized cancer diagnosis and treatment models, cross-border patient services, and cooperation in innovative therapies. The delegation included Professor Nguyen Van Kinh, founder of gene therapy in Vietnam; Mr. Chen Deqiang, CEO of MHC Holdings; and Mr. Wu Hainan, COO of Vitalwave Vietnam. Professor Li Dinggang, Chief Consultant for International Medical Services at Guangzhou RoyalLee Cancer Hospital; CEO Yeo Kim Seck; Vice President Ma Lanying; Assistant to the President Tang Haibo; and Pan Qi, Director of the Brand Promotion Center, extended a warm reception and held an in-depth symposium.

On-Site Visit: Internationalized Diagnostic and Treatment System Highly Praised by the Delegation
During the visit, accompanied by hospital leaders, the Vietnamese delegation toured the hospital’s International Medical Center, the Advanced Cancer Diagnosis and Treatment Equipment Zone, and the one-stop cross-border medical service supporting area. They observed up close the hospital’s standardized cancer diagnosis and treatment processes, high-end specialized medical equipment configuration, and full-process international medical service system. The hospital’s full-process closed-loop international patient service model, mature specialized cancer diagnosis and treatment capabilities, and globally aligned medical quality control system left a deep impression on the Vietnamese guests.
In-Depth Discussion: Starting with Tumor Rehabilitation to Expand Cooperation Boundaries
In his welcome address, CEO Yeo Kim Seck extended a warm welcome to the delegation and introduced the hospital’s development philosophy and plans. He stated that RoyalLee has always linked high-quality global medical resources with an open attitude and looks forward to using this exchange as a bond to promote mutual learning between China and Vietnam in the field of cancer prevention and treatment. The hospital is willing to share its internationalized diagnosis and treatment experience with Vietnamese counterparts so that cross-border medical cooperation can better benefit patients in both countries.

Yeo Kim Seck, CEO of Guangzhou RoyalLee Cancer Hospital
In his speech, Professor Li Dinggang proposed preliminary cooperation ideas: both sides have accumulated experience in tumor rehabilitation, and cooperation can start in this field, adopting a point-to-area approach to gradually advance in-depth cooperation in academic exchanges, translation of innovative achievements, and patient referral. He emphasized that China and Vietnam are highly complementary in cancer prevention and treatment and should take patient benefit as a common benchmark, gradually elevating single-point cooperation into a long-term mechanism. Both sides can jointly build a model for cross-border tumor rehabilitation cooperation, providing a replicable practical pathway for regional collaborative development in cancer prevention and treatment.

Professor Li Dinggang, Chief International Medical Consultant

Assistant to the President Tang Haibo
At the symposium, Professor Nguyen Van Kinh said that cancer is a major global public health challenge, and Vietnam is facing severe challenges. The purpose of this visit to Guangzhou was to learn from Guangzhou RoyalLee Cancer Hospital’s mature overseas medical operation experience and its clinical practice in innovative drugs and advanced therapies. He looked forward to further deepening exchanges and cooperation between the two sides to provide higher-quality medical services for Vietnamese cancer patients. Mr. Chen Deqiang said that MHC Holdings will establish specialized cancer rehabilitation and wellness institutions in Vietnam and looks forward to in-depth exchanges and learning from RoyalLee, so as to bring the mature experience of medical institutions back to Vietnam.

Professor Nguyen Van Kinh, Founder of Gene Therapy in Vietnam

MHC Holdings CEO Chen Deqiang

Vitalwave Vietnam COO Wu Hainan
Both sides agreed to continue refining cooperation plans, accelerate the implementation of more cooperative outcomes, bring China’s advanced cancer prevention and treatment experience to Vietnam, and benefit Vietnamese cancer patients.

This visit and exchange laid a solid foundation for future cooperation between the two sides. RoyalLee will continue to connect high-quality medical resources with an international perspective, undertake cross-border cooperation with its specialized cancer capabilities, and promote pragmatic exchanges and collaborative development in the field of China-Vietnam cancer prevention and treatment.
(+86)18613012387
info@royallee.cn
EN
CN
TH
IDN
AR





